Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Marc Cabrera Hurtado

Marc Cabrera Hurtado

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca
Marc Cabrera Hurtado

Marc Cabrera Hurtado

Marc Cabrera Hurtado

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Related news

Investigadora VHIR pipeta

European Partnership Opens a New Era in Rare Disease Research

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

tecniques-micro

VHIR leads a gene therapy study to stop the progression of neurodegenerative diseases

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Begona-Benito-Antonio-Roman-David-Gomez

Vall d'Hebron trains future professionals in the use of gene therapy

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

See more

Related professionals

Anna Sanjuan Viaplana

Anna Sanjuan Viaplana

Medium Grade Technician
Statistics and Bioinformatics Unit (UEB)
Digital Transformation Directorate
Read more
Pascual González, Gabriel

Pascual González, Gabriel

Cardiovascular Diseases
Read more
Joan Compte Barrón

Joan Compte Barrón

Predoctoral researcher
Neurodegenerative Diseases
Read more
Palau Continente, Dolors

Palau Continente, Dolors

Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.